Navigation Links
FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Date:1/31/2008

ctors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A. "Risk Factors" in the Schering-Plough's third quarter 2007 10-Q.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Mirus Bio Awarded Grants & Contracts of Over $5 Million
2. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
3. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
4. NIH grants $750,000 to develop device to determine temperature of neonates brain
5. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
6. Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis
7. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
8. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
9. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
10. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
11. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Nursing Care at Hahnemann among the Best in ... -- Hahnemann University Hospital proudly announces it has ... Credentialing Center,s (ANCC) Magnet Recognition Program(R). Magnet(R) is ... hospital or medical center can achieve, and places ... the country that have achieved this prestigious distinction. ...
(Date:12/16/2009)... Resources, one of the world,s leading research and ... that, according to responses from surveyed dermatologists, Centocor ... inhibitors) will capture 22 percent of the biologics ... moderate to severe psoriasis. Among these two agents, ... times as much patient share as briakinumab. ...
(Date:12/16/2009)... the ultimate CHO cell culture supplement? InVitria has what scientists ... culture media supplement that improves the growth and productivity of ... performance, Zap-CHO is an animal free, well defined and consistent ... ... Collins, CO (PRWEB) December 16, 2009 -- Scientists working with ...
(Date:12/15/2009)... Calif., Dec. 15 Epeius Biotechnologies Corporation, ... genetic medicine, gained international validation of the cutting-edge ... , when scientists around the world rediscovered the ... major locus of cancer pathogenesis and disease progression, ... Recently, scientists at the NIH National Cancer Institute ...
Breaking Biology Technology:Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... successful debut at the Medical Design & Manufacturing East Show. , ... ... of Zeus, Inc., made a successful debut at the Medical Design & ... Convention Center in New York. , , ,"The MD&M East show ...
... Calif. - Researchers have identified a signature for water ... is structured and how it moves within these tiny ... able to get a snapshot of the water inside ... the potential to act as a unique nanofiltration system. ...
... WoundStat™ – today announced that the company has received the prestigious ... production and sales of medical devices. The company received FDA clearance ... ... BETHESDA, Md. (Business Wire EON) June 24, 2008 -- With ...
Other Biology Technology:Polymathic Analytical Labs Debuts at World's Largest Medical Design & Manufacturing Exhibition 2LLNL researchers peer into water in carbon nanotubes 2 TraumaCure Receives Prestigious ISO 13485 Certification 2
(Date:12/16/2009)... cells, molecules form an intricate network of interactions. ... measure individual molecular reactions outside the cells. Since ... in the laboratory, scientists suspect that the kinetics ... from external probes. We expected the cellular reaction ... Dieter Braun. "However, our novel optical approach showed ...
(Date:12/16/2009)... Signal Hill, CA Tom Bowman, an expert in ... Bowman Global Change, has developed a series of graphics ... on Climate Change (IPCC) report for public audiences. These ... information they need to make informed decisions about climate ... format as a means to clearly and accurately communicate ...
(Date:12/16/2009)... REDWOOD CITY, Calif., Dec. 2 ... and authentication solutions, today announced an agreement ... of its DigitalPersona biometric fingerprint technology on ... U.are.U® 4500HD offering allows point-of-sale applications to ... that specific transactions can be linked to ...
Breaking Biology News(10 mins):Looking for the heartbeat of cellular networks 2Bowman creates graphic translation of climate change data 2DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Capping a two faced particle gives duke engineers complete control 13514 1Capping a two faced particle gives duke engineers complete control 13514 2Cryo Cell Announces Strategic Partnership With S Evans Biosciences Inc 13512 1Cryo Cell Announces Strategic Partnership With S Evans Biosciences Inc 13512 2Cryo Cell Announces Strategic Partnership With S Evans Biosciences Inc 13512 3Cryo Cell Announces Strategic Partnership With S Evans Biosciences Inc 13512 4Cryo Cell Announces Strategic Partnership With S Evans Biosciences Inc 13512 5Cryo Cell Announces Strategic Partnership With S Evans Biosciences Inc 13512 6Caraco Pharmaceutical Laboratories Ltd Markets Generic Imitrex 28R 29 Tablets 54270 1Caraco Pharmaceutical Laboratories Ltd Markets Generic Imitrex 28R 29 Tablets 54270 2
... Va. -- Choices and Challenges, an annual forum at Virginia ... the trend with the literally heated and topical subject of ... discussions will be held on Thursday, Nov. 8, at the ... Life Center at Donaldson Brown. This forum is open to ...
... price for all types of gasoline is holding steady ... the pump might be short-lived as research from the ... hurdles to the wide-scale production of fuel cell-powered vehicles., ... engineering, led the research team in discovering a method ...
... is believed to benefit the soil by building organic ... this view based on analyses of soil samples from ... current practice began. , The research, also drawing upon ... conducted by U of I soil scientists Saeed Khan, ...
Other Biology News:Choices and Challenges forum to address nuclear power issue 2Fuel cells gearing up to power auto industry 2Fuel cells gearing up to power auto industry 3Study reveals that nitrogen fertilizers deplete soil organic carbon 2Study reveals that nitrogen fertilizers deplete soil organic carbon 3